Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

HTLV-1 infection in solid organ transplant donors and recipients in Spain.

de Mendoza C, Roc L, Benito R, Reina G, Ramos JM, Gómez C, Aguilera A, Rodríguez-Iglesias M, García-Costa J, Fernández-Alonso M, Soriano V; Spanish HTLV Network.

BMC Infect Dis. 2019 Aug 9;19(1):706. doi: 10.1186/s12879-019-4346-z.

2.

HTLV testing of solid organ transplant donors.

de Mendoza C, Roc L, Fernández-Alonso M, Soriano V; Spanish HTLV Network.

Clin Transplant. 2019 Jul 18:e13670. doi: 10.1111/ctr.13670. [Epub ahead of print]

PMID:
31321817
3.

Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.

Yendewa GA, Sahr F, Lakoh S, Ruiz M, Patiño L, Tabernilla A, Deen GF, Sesay M, Salata RA, Poveda E.

J Antimicrob Chemother. 2019 Jul 1;74(7):2024-2029. doi: 10.1093/jac/dkz134.

4.

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone.

Yendewa GA, Sahr F, Aguilera A, Lakoh S, Sesay M, Deen GF, Patiño L, Poveda E, Salata RA.

Am J Trop Med Hyg. 2019 Jun;100(6):1521-1524. doi: 10.4269/ajtmh.18-1001.

PMID:
30938283
5.

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice.

Alvarez M, Casas P, de Salazar A, Chueca N, Guerrero-Beltran C, Rodríguez C, Imaz A, Espinosa N, García-Bujalance S, Pérez-Elías MJ, García-Alvarez M, Iribarren JA, Santos J, Dalmau D, Aguilera A, Vinuesa D, Gutiérrez F, Piérola B, Molina JM, Peraire J, Portilla I, Gómez-Sirvent JL, Olalla J, Galera C, Blanco JR, Riera M, García-Fraile L, Navarro G, Curran A, Poveda E, García F; CoRIS .

J Antimicrob Chemother. 2019 Jun 1;74(6):1693-1700. doi: 10.1093/jac/dkz067.

PMID:
30838386
6.

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain.

De Mendoza C, Pirón M, Gonzalez R, Jiménez A, Caballero E, Roc L, Benito R, Ramos JM, Soriano V; HTLV Spanish Study Group .

Open Forum Infect Dis. 2019 Jan 16;6(2):ofz036. doi: 10.1093/ofid/ofz036. eCollection 2019 Feb.

7.

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Cid-Silva P, Margusino-Framiñán L, Balboa-Barreiro V, Pernas-Souto B, Mena-De-Cea Á, Martín-Herranz I, Castro-Iglesias Á, Poveda E.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218821940. doi: 10.1177/2325958218821940.

PMID:
30798655
8.

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

Cid-Silva P, Fernández-Bargiela N, Margusino-Framiñán L, Balboa-Barreiro V, Mena-De-Cea Á, López-Calvo S, Vázquez-Rodríguez P, Martín-Herranz I, Míguez-Rey E, Poveda E, Castro-Iglesias Á.

Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):479-490. doi: 10.1111/bcpt.13161. Epub 2018 Dec 7.

PMID:
30388308
9.

High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone.

Yendewa GA, Poveda E, Lakoh S, Yendewa SA, Jiba DF, Salgado-Barreira A, Sahr F, Salata RA.

Open Forum Infect Dis. 2018 Aug 23;5(9):ofy208. doi: 10.1093/ofid/ofy208. eCollection 2018 Sep.

10.

HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.

Yendewa GA, Poveda E, Yendewa SA, Sahr F, Quiñones-Mateu ME, Salata RA.

AIDS Rev. 2018 Apr-Jun;20(2):104-113. Review.

PMID:
29938704
11.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan:.

Enferm Infecc Microbiol Clin. 2019 Mar;37(3):195-202. doi: 10.1016/j.eimc.2018.02.010. Epub 2018 Jun 18. English, Spanish.

PMID:
29759422
13.

Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies.

Grandal M, Pernas B, Tabernilla A, Mariño A, Álvarez H, Valcarce N, Mena A, Castro-Iglesias A, Pérez AB, Delgado M, Poveda E.

J Med Virol. 2018 Jun;90(6):1094-1098. doi: 10.1002/jmv.25048. Epub 2018 Mar 12.

PMID:
29427437
14.

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.

Cid-Silva P, Margusino-Framiñán L, Balboa-Barreiro V, Martín-Herranz I, Castro-Iglesias Á, Pernas-Souto B, Llibre JM, Poveda E.

AIDS. 2018 Jan 2;32(1):121-125. doi: 10.1097/QAD.0000000000001679.

PMID:
29112068
15.
16.

Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication.

Pernas B, Rego-Pérez I, Tabernilla A, Balboa V, Relaño S, Grandal M, Crespo M, Mena Á, Castro-Iglesias Á, Blanco FJ, Poveda E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3159-3162. doi: 10.1093/jac/dkx272.

PMID:
28961892
17.

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance.

Cid-Silva P, Llibre JM, Fernández-Bargiela N, Margusino-Framiñán L, Balboa-Barreiro V, Pernas-Souto B, Martín-Herranz I, Castro-Iglesias Á, Poveda E.

Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):442-446. doi: 10.1111/bcpt.12828. Epub 2017 Jul 16.

18.

Minimizing Next-Generation Sequencing Errors for HIV Drug Resistance Testing.

Fernández-Caballero JA, Chueca N, Poveda E, García F.

AIDS Rev. 2017 Oct-Dec;19(4):231-238. Review.

PMID:
28534892
19.

When is Early Antiretroviral Therapy Early Enough for HIV Remission?

Poveda E, Crespo M.

AIDS Rev. 2017 Apr - Jun;19(2):113-114. Review.

PMID:
28534887
20.

Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.

Meijide H, Pértega S, Rodríguez-Osorio I, Castro-Iglesias Á, Baliñas J, Rodríguez-Martínez G, Mena Á, Poveda E.

AIDS. 2017 May 15;31(8):1099-1107. doi: 10.1097/QAD.0000000000001448.

PMID:
28441174

Supplemental Content

Loading ...
Support Center